The regulation of host defences to infection by the microbiota

Immunology

Volumn 150, Issue 1, 2017, Pages 1-6

  Brown, Rebecca L ^a   Clarke, Thomas B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

bacterial; inflammation; lung; mucosa; Toll like receptors

Indexed keywords

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; INTESTINE INFECTION; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; ANIMAL; BACTERIUM; HOMEOSTASIS; IMMUNOLOGY; INFECTION; METABOLISM; MICROBIOLOGY; MUCOSAL IMMUNITY;

PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ANIMALS; BACTERIA; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, MUCOSAL; INFECTION; MICROBIOTA; RECEPTORS, PATTERN RECOGNITION;

EID: 84982993780     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12634     Document Type: Review

References (79)

1. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837–48.
2. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13:260–70.
3. Gill SR, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355–9.
4. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011; 140:1713–9.
5. Dominguez-Bello MG, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107:11971–5.
6. Costello EK, et al. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694–7.
7. Yatsunenko T, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222–7.
8. de Steenhuijsen Piters WA, Sanders EA, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond B Biol Sci. 2015; 370: 20140294.
9. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213–23.
10. Ussar S, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab 2015; 22:516–30.
11. Kubinak JL, et al. MHC variation sculpts individualized microbial communities that control susceptibility to enteric infection. Nat Commun 2015; 6:8642.
12. Blekhman R, et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol 2015; 16:191.
13. Hoffmann C, et al. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun 2009; 77:4668–78.
14. Hsiao A, et al. Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 2014; 515:423–6.
15. Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol 2012; 33:459–66.
16. Cho I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488:621–6.
17. Cox LM, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014; 158:705–21.
18. Nobel YR, et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun 2015; 6:7486.
19. Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. J Clin Invest 2014; 124:4212–8.
20. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012; 30:759–95.
21. Hill DA, Artis D. Maintaining diplomatic relations between mammals and beneficial microbial communities. Sci Signal 2009; 2: pe77.
22. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010; 28:623–67.
23. Fung TC, Artis D, Sonnenberg GF. Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev 2014; 260:35–49.
24. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12:383–90.
25. Molloy MJ, Bouladoux N, Belkaid Y. Intestinal microbiota: shaping local and systemic immune responses. Semin Immunol 2012; 24:58–66.
26. Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 2013; 14:646–53.
27. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014; 157:121–41.
28. Hergott CB, et al. Detection of peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. Blood 2016; 127:2460–71.
29. Clarke TB, et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16:228–31.
30. Clarke TB. Microbial programming of systemic innate immunity and resistance to infection. PLoS Pathog 2014; 10:e1004506.
31. Seo SU, et al. Distinct commensals induce interleukin-1β via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity 2015; 42:744–55.
32. Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011; 10:311–23.
33. Mathis D, Benoist C. The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol Rev 2012; 245:239–49.
34. Kriegel MA, et al. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA 2011; 108:11548–53.
35. Van Praet JT, et al. Commensal microbiota influence systemic autoimmune responses. EMBO J 2015; 34:466–74.
36. Taur Y, Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 2013; 26:332–7.
37. Schuijt TJ, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016; 65:575–83.
38. Kinnebrew MA, Pamer EG. Innate immune signaling in defense against intestinal microbes. Immunol Rev 2012; 245:113–31.
39. Khosravi A, et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014; 15:374–81.
40. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14:685–90.
41. Ichinohe T, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011; 108:5354–9.
42. Clarke TB. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun 2014; 82:4596–606.
43. Chu H, Mazmanian SK. Innate immune recognition of the microbiota promotes host–microbial symbiosis. Nat Immunol 2013; 14:668–75.
44. Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 2012; 12:503–16.
45. Vaishnava S, et al. The antibacterial lectin RegIIIγ promotes the spatial segregation of microbiota and host in the intestine. Science 2011; 334:255–8.
46. Brandl K, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008; 455:804–7.
47. Ivanov II, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485–98.
48. Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 2015; 33:227–56.
49. World Health Organization. Global Health Estimates: Causes of death 2000–2012. Geneva, Switzerland: World Health Organization, 2014.
50. Weiser JN. The pneumococcus: why a commensal misbehaves. J Mol Med (Berl) 2010; 88:97–102.
51. Parker D, Ahn D, Cohen T, Prince A. Innate immune signaling activated by MDR bacteria in the airway. Physiol Rev 2016; 96:19–53.
52. Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 2011; 45:189–201.
53. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008; 8:142–52.
54. Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 2014; 14:81–93.
55. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819–26.
56. Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity 2006; 25:373–81.
57. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015; 16:343–53.
58. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338–44.
59. Medzhitov R, Janeway CA Jr. An ancient system of host defense. Curr Opin Immunol 1998; 10:12–5.
60. Nathan C. Points of control in inflammation. Nature 2002; 420:846–52.
61. Gauguet S, et al. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect Immun 2015; 83:4003–14.
62. Fagundes CT, et al. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J Immunol 2012; 188:1411–20.
63. Chen LW, Chen PH, Hsu CM. Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. Shock 2011; 36:67–75.
64. Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol 2015; 33:747–85.
65. Wang J, et al. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat Commun 2013; 4:2106.
66. Abt MC, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012; 37:158–70.
67. Deshmukh HS, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014; 20:524–30.
68. Ganal SC, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012; 37:171–86.
69. Balmer ML, et al. Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. J Immunol 2014; 193:5273–83.
70. Wirths S, Bugl S, Kopp HG. Neutrophil homeostasis and its regulation by danger signaling. Blood 2014; 123:3563–6.
71. Karmarkar D, Rock KL. Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response. Immunology 2013; 140:483–92.
72. Chou HH, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA 2015; 112:2175–80.
73. Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol 2014; 32:367–402.
74. Erny D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18:965–77.
75. Yano JM, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015; 161:264–76.
76. Hsiao EY, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155:1451–63.
77. Quintin J, Cheng SC, van der Meer JW, Netea MG. Innate immune memory: towards a better understanding of host defense mechanisms. Curr Opin Immunol 2014; 29:1–7.
78. Brodin P, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 2015; 160:37–47.
79. Arrieta MC, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 2015; 7: 307ra152.